NCT03659305 - Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

January 26, 2019

Study Completion Date

January 26, 2019

Conditions

Healthy

Interventions

BIOLOGICAL

RPH-001

Concentrate for preparation solution for infusion in ampules, 25 mg/mL

BIOLOGICAL

Avastin

Concentrate for preparation solution for infusion in ampules, 25 mg/mL

Trial Locations (1)

SBHI Krasnogorskaya City Hospital #1, Krasnogorsk